Propidium Iodide Workflows for Cell Fate Analysis
2026-08-13
Propidium iodide provides a fast, fluorescence-based readout of membrane compromise for viability, apoptosis, and cell-cycle experiments. This workflow shows how to pair the dye with controls, flow cytometry, and orthogonal endpoints so drug-response results are interpretable rather than merely fluorescent.
Lithium, Rab11a, and Exosomal Wnt10a in Osteogenesis
2026-08-12
The reference study identifies a mechanistic route by which lithium enhances BMSC osteogenesis: MARK2-associated trafficking of Rab11a/Rab11FIP1 complexes promotes exosomal Wnt10a secretion and Wnt/β-catenin activation. It further shows that lithium-conditioned exosomes and GelMA hydrogel delivery improve osteogenic outcomes in experimental models, while highlighting important translational questions about dose, vesicle characterization, and clinical transferability.
AG-120 (Ivosidenib) and Mutant IDH1 Biology
2026-08-12
AG-120, also called Ivosidenib, is an oral inhibitor of mutant IDH1 that lowers the oncometabolite 2-hydroxyglutarate. Preclinical AML models connect this pharmacodynamic effect with erythropoietin-induced differentiation and myeloid maturation, while clinical studies support activity in selected IDH1-mutant leukemias and solid tumors.
ARCA Cap Analog for Synthetic mRNA
2026-08-11
Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, is an orientation-selective Cap 0 analog for in vitro transcription. Product information reports approximately twofold higher translation than conventional m7G cap analogs under the stated comparison, while peer-reviewed work supports the broader role of capped synthetic mRNA in cellular reprogramming research.
Protease Inhibitor Cocktail: MS-SAFE Workflow
2026-08-10
Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) helps limit endogenous proteolysis during cell and tissue protein extraction, including workflows intended for mass spectrometry. It should not be treated as complete metalloproteinase protection without separately validated EDTA, and DMSO compatibility must be checked for each downstream assay.
DiD (DiDC 18 (5)) for Membrane Tracking
2026-08-09
DiD (DiDC 18 (5)) combines uniform red plasma-membrane labeling with compatibility for live-cell tracking, fixation, and immunofluorescence. Its longer-wavelength performance is especially useful for neuronal tracing, cell migration tracking, and inflammatory tissue models where autofluorescence can obscure shorter-wavelength dyes.
BCECF-AM for Intracellular pH and Autophagy
2026-08-08
BCECF-AM combines membrane-permeable loading with ratiometric fluorescence for resolving live-cell pH changes without relying on absolute signal intensity. This guide translates the SINAT–VAB1 Arabidopsis autophagy findings into practical assay design, workflow controls, and troubleshooting strategies for plant and mammalian studies.
CTOP: Mapping μ-Opioid Signaling in Pain
2026-08-07
CTOP is a selective μ-opioid receptor antagonist for dissecting receptor-dependent signaling in neuropharmacology and pain mechanism research. This guide connects CTOP-based pharmacological perturbation with a brain-to-spinal circuit implicated in opioid-induced mechanical hypersensitivity and tolerance.
Coordinated DNA and RNA Methylation Drives EGFR-TKI Resistan
2026-08-07
This study uncovers how coordinated DNA 5-mC and RNA m5C methylation regulates alternative splicing of the MZF1 gene, influencing resistance to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer. By delineating an epigenetic axis involving UHRF1/DNMT1 and NSUN7/YBX1, the research highlights new biomarkers and therapeutic targets for overcoming drug resistance.
Dimetridazole: Redefining Synergy in Antimicrobial Innovatio
2026-08-06
Explore how Dimetridazole, a nitroimidazole-class agent, is transforming multidrug-resistant infection research through membrane disruption, quorum sensing inhibition, and powerful synergy with β-lactams. This article provides mechanistic insights, protocol guidance, and strategic context for translational researchers seeking to leverage Dimetridazole in advanced infection models and biofilm suppression studies.
Triacetin in Biochemical Research: Protocols and Troubleshoo
2026-08-06
Triacetin (glyceryl triacetate) is redefining metabolic and antitumor assays, enabling precise modulation of cell fate and lipid signaling. This guide delivers actionable protocols, troubleshooting insights, and context from leading studies, positioning APExBIO’s Triacetin as a cornerstone for advanced biochemical workflows.
EZ Cap™ OVA mRNA: Optimizing Immunogen Delivery Workflows
2026-08-05
EZ Cap™ OVA mRNA streamlines immune research with high-purity, Cap 1-capped ovalbumin transcripts, enabling precise modeling and efficient protein expression. Integrating this immunogen with advanced low-inflammation delivery systems, such as mildronate-derived lipid nanoparticles, sets a new standard for reproducibility and safety in vaccine development research.
Nadolol (SQ-11725) in Experimental Pharmacokinetics: Beyond
2026-08-05
Explore Nadolol (SQ-11725) as a research catalyst for pharmacokinetic and transporter studies, with unique insights into OATP1A2-mediated distribution and protocol optimization. This article provides advanced guidance for hypertension research and angina pectoris studies.
Dimetridazole-Cefotaxime Synergy Disrupts MDR E. coli Membra
2026-08-04
Wei et al. reveal that combining dimetridazole, a 1,2-dimethyl-5-nitroimidazole, with cefotaxime restores antibiotic efficacy against multidrug-resistant E. coli. The synergy relies on disruption of bacterial membrane integrity and fatty acid biosynthesis, offering a mechanistic advance for tackling antimicrobial resistance.
Camostat Mesilate as a Trypsin-like Protease Inhibitor: Appl
2026-08-04
Camostat Mesilate empowers researchers with precise, reproducible control over airway ENaC function and TGF-β signaling—critical for fibrosis and PPI studies. This article delivers actionable protocol enhancements, troubleshooting strategies, and translational workflow insights, bridging mechanistic understanding with advanced experimental needs.
464 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page